Barriers to Use of Pharmacotherapy for Addiction Disorders and How to Overcome Them
- 20 July 2011
- journal article
- research article
- Published by Springer Science and Business Media LLC in Current Psychiatry Reports
- Vol. 13 (5), 374-381
- https://doi.org/10.1007/s11920-011-0222-2
Abstract
Substance use disorders are highly prevalent, debilitating conditions for which effective pharmacotherapies exist with a broad evidence base, yet pharmacotherapy for the treatment of addiction disorders is underutilized. The goals of this review are to describe the barriers that may contribute to poor adoption and utilization of pharmacotherapy for alcohol and opioid dependence at the system, provider, and patient level and to discuss ways to overcome those barriers. Multifaceted efforts directed at all three levels may be needed to speed pharmacotherapy adoption. More research is needed to help us better understand barriers from patients’ perspectives. Strategies to promote adoption of pharmacotherapy for addiction disorders should be modified to fit the needs of the practice, system, and individual patients. Pharmacotherapy is a valuable tool in the clinical armamentarium of addiction treatment; thus, overcoming barriers to implementation may improve clinical and social outcomes.Keywords
This publication has 71 references indexed in Scilit:
- Using medication-assisted treatment for substance use disorders: Evidence of barriers and facilitators of implementationAddictive Behaviors, 2011
- Counselor attitudes toward the use of naltrexone in substance abuse treatment: A multi-level modeling approachAddictive Behaviors, 2011
- Methadone maintenance and the cost and utilization of health care among individuals dependent on opioids in a commercial health planDrug and Alcohol Dependence, 2010
- The Physician Clinical Support System-Buprenorphine (PCSS-B): a Novel Project to Expand/Improve Buprenorphine TreatmentJournal of General Internal Medicine, 2010
- Alcohol and opioid dependence medications: Prescription trends, overall and by physician specialtyDrug and Alcohol Dependence, 2009
- Integrating Buprenorphine Treatment into Office-based Practice: a Qualitative StudyJournal of General Internal Medicine, 2008
- Office-Based Management of Opioid Dependence with Buprenorphine: Clinical Practices and BarriersJournal of General Internal Medicine, 2008
- Availability of addiction medications in private health plansJournal of Substance Abuse Treatment, 2008
- Barriers to Obtaining Waivers to Prescribe Buprenorphine for Opioid Addiction Treatment Among HIV PhysiciansJournal of General Internal Medicine, 2007
- The adoption of medications in substance abuse treatment: Associations with organizational characteristics and technology clustersDrug and Alcohol Dependence, 2007